tirzepatide bowel obstruction Benign small pneumatosis intestinalis: report of a rare adverse effect of Tirzepatide vs. Gastroparesis Side Effects:

Walker CS, Aitken JF, Vazhoor Amarsingh G, Zhang S, Cooper GJS

Journal of medicinal food

In September, Ascendis sold 3% of Yorvipath royalties to Royalty Pharma for $150 million and, later in the same month, sold $281 million in shares following approval of Yorvipath

Unfortunately, the drug is usually prescribed in a higher dose when used for weight loss, possibly increasing the risk that a patient will develop severe side effects such as gastroparesis, malnutrition-related disorders, deep vein thrombosis, and bowel obstruction

It's essential to remember that these raised areas can differ in size and may merge, forming larger plaques